Background: Geraniol (GE), as secondary metabolites of plant and natural bioactive essential oils is one of the major compounds of Rosa damascena Mill and widely used as fragrance/flavor in the food industry. Rosa damascena Mill and geraniol have numerous health benefits for human consumption. Currently, there is no single article that extensively covers the complete range of beneficial effects of GE that could improve knowledge in this category. 
Objective: The purpose of this study was to provide a comprehensive review of all published specific articles about beneficial properties of GE, as a monoterpene component of medicinal plants. 
Methods: Data were selected from Scopus, Clarivate Web Of ScienceTM, Embase, ScienceDirect and PubMed databases from 1940-2019 by identifying keywords and creating complex searches. 
Results: Based on the search results, GE identified as a natural compound having insecticidal and repellent activities. GE introduces a new class of cancer chemopreventive agents due to its citronellol and trans-geraniol. Other functional properties such as antibacterial, antifungal, antioxidant and anti-inflammatory of GE have also been found. 
Conclusion: Overall, this approach has been a systematic literature review to provide an effective strategy for rapidly evaluating research results. This study suggests that the GE and Rosa damascena Mill have multiple health benefits and they are recommended for their therapeutic effects.
Keywords: Geraniol; Medicinal plant; Bioactivity; Rosa damascene


» HTML Fulltext    » PDF Fulltext    » doi: 10.19082/7724
Air Jordan

The  most recent editorial (June 2021)

Ethics of Publishing Case Reports: Do We Need Ethics Approval and Patient Consent?

An editorial by Dr. Mehrdad Jalalian

Read more.

The worldwide spread of COVID-19 as an emerging, rapidly evolving situation, and the dramatic need of urgent medicine or vaccine, has rapidly brought new hypotheses for pathophysiology and potential medicinal agents to the fore. It is crucial that the research community provide a way to publish this research in a timely manner.


To contribute to this important public health discussion, the Electronic Physician Journal is excited to announce a fast-track procedure to help researchers publish their articles on COVID-19 related subjects that fall under the broad definition of public health, internal medicine, and pharmacology. We are especially welcome to all hypotheses about the pathological basis of the COVID-19 infection and the possible characteristics of potential medicine and vaccine. Submit your manuscript here


Our previous editorial (June 2020)

Lessons from COVID-19 pandemic and the Morocco’s success story.

An editorial by Dr. Benksim Abdelhafid (Morocco)

Read more.


The 6th World Conference on Research Integrity (WCRI) is to be held on June 2-5, 2019 in Hong Kong.

The WCRI is the largest and most significant international conference on research integrity. Since the first conference in Lisbon in 2007, it has given researchers, teachers, funding agencies, government officials, journal editors, senior administrators, and research students opportunities to share experiences and to discuss and promote integrity in research. Read more:


TDR Clinical Research and Development Fellowships

Call for applications

Deadline for submission: 7 March 2019, 16:00 (GMT)

TDR provides fellowships for early- to mid-career researchers and clinical trial staff (e.g. clinicians, pharmacists, medical statisticians, data managers, other health researchers) in low- and middle-income countries (LMICs) to learn how to conduct clinical trials. Read more:

Meta-Analysis Workshops in New York, USA, and London, UK, in April and May 2019

Don't miss this exceptional opportunity to learn how to perform and report a Meta-analysis correctly. Two Meta-analysis workshops are organized in April and May 2019 by Dr. Michael Borenstein in New York, USA (April 08-10, 2019) and London, UK (May 27-29).

About the Instructor

Dr. Michael Borenstein, one of the authors of Introduction to Meta-Analysis, is widely recognized for his ability to make statistical concepts accessible to researchers as well as to statisticians. He has lectured widely on meta-analysis, including at the NIH, CDC, and FDA. Read more: